Hoya (OTCMKTS:HOCPY – Get Free Report) is projected to post its results after the market closes on Friday, October 30th. Analysts expect the company to announce earnings of $1.28 per share and revenue of $1.67 billion for the quarter.
Hoya (OTCMKTS:HOCPY – Get Free Report) last announced its earnings results on Friday, July 31st. The technology company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.10. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.55 billion. Hoya had a return on equity of 25.78% and a net margin of 27.58%. On average, analysts expect Hoya to post $5.26 EPS for the current fiscal year and $5.91 EPS for the next fiscal year.
Hoya Stock Performance
HOCPY opened at $169.14 on Thursday. The company has a quick ratio of 4.20, a current ratio of 4.91 and a debt-to-equity ratio of 0.03. The stock’s 50 day moving average price is $155.00 and its two-hundred day moving average price is $166.04. The firm has a market capitalization of $56.63 billion, a P/E ratio of 33.56, a price-to-earnings-growth ratio of 3.45 and a beta of 0.97. Hoya has a 12-month low of $140.90 and a 12-month high of $190.18.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded shares of Hoya from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, September 30th. One investment analyst has rated the stock with a Strong Buy rating. According to data from MarketBeat, Hoya has an average rating of “Strong Buy”.
Read Our Latest Research Report on Hoya
About Hoya
HOYA Corporation is a Japan-based technology and healthcare company that develops and manufactures optical products and precision components. Founded in 1941 as an optical glass manufacturer, the company has expanded into medical devices, vision care, and advanced technologies used in semiconductor production and other industrial applications.
Through its Life Care businesses, HOYA provides prescription eyeglass lenses, contact lenses, intraocular lenses used in cataract surgery, and medical equipment such as endoscopic systems.
Read More
- Five stocks we like better than Hoya
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Hoya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya and related companies with MarketBeat.com's FREE daily email newsletter.
